Heart Test Laboratories Inc Common Stock (HSCS) had the best quarter in 2022 by a US stock in Q2 2022, returning 551,076.5%.

ASSET	QUARTER	% RETURN
Heart Test Laboratories Inc Common Stock (HSCS)	Q2 2022	551,076.47%
SS Innovations International Inc Common Stock (SSII)	Q4 2022	22,854.55%
Castellum (CTM)	Q4 2022	12,375.25%
Lottery (SEGG)	Q2 2022	7,732.17%
Foremost Lithium Resource & Technology Ltd Common stock (FMST)	Q4 2022	3,257.14%
Tian Ruixiang (TIRX)	Q4 2022	2,855.87%
Foremost Lithium Resource & Technology Ltd Common stock (FMST)	Q2 2022	2,158.33%
Cabaletta Bio (CABA)	Q4 2022	1,301.52%
ENDRA Life Sciences (NDRA)	Q4 2022	1,233.06%
Electra Battery Materials (ELBM)	Q2 2022	1,080.7%
Indonesia Energy (INDO)	Q1 2022	697.74%
Integrated Media Technology (IMTE)	Q1 2022	605.48%
Rhythm Pharmaceuticals (RYTM)	Q3 2022	500.49%
Ucloudlink (UCL)	Q4 2022	464%
ProQR Therapeutics (PRQR)	Q4 2022	388.38%
Madrigal Pharmaceuticals (MDGL)	Q4 2022	336.6%
PDS Biotechnology (PDSB)	Q4 2022	335.64%
AMTD Digital (HKD)	Q3 2022	260%
Summit Therapeutics (SMMT)	Q4 2022	254.17%
Hycroft Mining (HYMC)	Q1 2022	253.85%
Viking Therapeutics (VKTX)	Q4 2022	240.58%
Kala Pharmaceuticals (KALA)	Q4 2022	240.02%
Biovie (BIVI)	Q4 2022	225.1%
Immunovant (IMVT)	Q4 2022	213.05%
Waterdrop Inc ADR (WDH)	Q4 2022	211.23%